본문 바로가기
KERD
논문KCI 등재

Drug-induced liver injury

Jeong Ill Suh
영남대학교 의과대학 (Yeungnam University College of Medicine)|2020.01|Journal of Yeungnam Medical Science|제37권 제1호|pp. 2-12|DOI 10.12701/yujm.2019.00297

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

ManagementDiagnosisHerbDrug-induced liver injury
주제분류의학일반

초록

Drug-induced liver injury (DILI), including herbal and dietary supplement hepatotoxicity, is often passed lightly; however, it can lead to the requirement of a liver transplant or may even cause death because of liver failure. Recently, the American College of Gastroenterology, Chinese Society of Hepatology and European Association for the Study of the Liver guidelines for the diagnosis and treatment of DILI have been established, and they will be helpful for guiding clinical treatment decisions. Roussel Uclaf Causality Assessment Method scoring is the most commonly used method to diagnose DILI; however, it has some limitations, such as poor validity and reproducibility. Recently, studies on new biomarkers have been actively carried out, which will help diagnose DILI and predict the prognosis of DILI. It is expected that the development of new therapies such as autophagy inducers and various other technologies of the fourth industrial revolution will be applicable to DILI research.

Abstract

Drug-induced liver injury (DILI), including herbal and dietary supplement hepatotoxicity, is often passed lightly; however, it can lead to the requirement of a liver transplant or may even cause death because of liver failure. Recently, the American College of Gastroenterology, Chinese Society of Hepatology and European Association for the Study of the Liver guidelines for the diagnosis and treatment of DILI have been established, and they will be helpful for guiding clinical treatment decisions. Roussel Uclaf Causality Assessment Method scoring is the most commonly used method to diagnose DILI; however, it has some limitations, such as poor validity and reproducibility. Recently, studies on new biomarkers have been actively carried out, which will help diagnose DILI and predict the prognosis of DILI. It is expected that the development of new therapies such as autophagy inducers and various other technologies of the fourth industrial revolution will be applicable to DILI research.

참고문헌 (61)

  1. Chalasani N, "Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States", Gastroenterology, 135, pp.1924~1934 (2008)
  2. Hayashi PH, "Long-term outcomes after drug-induced liver injury", Curr Hepatol Rep, 17, pp.292~299 (2018)
  3. Zhu Y, "Hepatobiliary and pancreatic : comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients", J Gastroenterol Hepatol, 31, pp.1476~1482 (2016)
  4. Lee WJ, "Systematic review on herb-induced liver injury in Korea", Food Chem Toxicol, 84, pp.47~54 (2015)
  5. Wysowski DK, "Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions", Arch Intern Med, 165, pp.1363~1369 (2005)
  6. Holt MP, "Mechanisms of drug-induced liver injury", AAPS J, 8, pp.E48~54 (2006)
  7. Chalasani NP, "ACG clinical guideline : the diagnosis and management of idiosyncratic drug-induced liver injury", Am J Gastroenterol, 109, pp.950~966 (2014)
  8. Yu YC, "CSH guidelines for the diagnosis and treatment of drug-induced liver injury", Hepatol Int, 11, pp.221~241 (2017)
  9. European Association for the Study of the Liver, "EASL clinical practice guidelines : drug-induced liver injury", J Hepatol, 70, pp.1222~1261 (2019)
  10. Fontana RJ, "Standardization of nomenclature and causality assessment in drug-induced liver injury : summary of a clinical research workshop", Hepatology, 52, pp.730~742 (2010)
  11. Devarbhavi H, "An update on drug-induced liver injury", J Clin Exp Hepatol, 2, pp.247~259 (2012)
  12. Bénichou C, "Criteria of drug-induced liver disorders. Report of an international consensus meeting", J Hepatol, 11, pp.272~276 (1990)
  13. Visentin M, "Drug-induced bile duct injury", Biochim Biophys Acta Mol Basis Dis, 1864, pp.1498~1506 (2018)
  14. Wang T, "A proposed pathologic sub-classification of drug-induced liver injury", Hepatol Int, 13, pp.339~351 (2019)
  15. Ahmad J, "Epidemiology and genetic risk factors of drug hepatotoxicity", Clin Liver Dis, 21, pp.55~72 (2017)
  16. Bell LN, "Epidemiology of idiosyncratic drug-induced liver injury", Semin Liver Dis, 29, pp.337~347 (2009)
  17. Suk KT, "A prospective nationwide study of drug-induced liver injury in Korea", Am J Gastroenterol, 107, pp.1380~1387 (2012)
  18. Danan G, "Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries", J Clin Epidemiol, 46, pp.1323~1330 (1993)
  19. Hayashi PH, "Overview of causality assessment in drug-induced liver injury", Clin Liver Dis(Hoboken), 9, pp.29~33 (2017)
  20. Hoofnagle JH, "Drug-induced liver injury network(DILIN)", Hepatology, 40, pp.773~ (2004)
  21. Hayashi PH, "Drug-induced liver injury network causality assessment : criteria and experience in the United States", Int J Mol Sci, 17, pp.201~ (2016)
  22. Antoine DJ, "High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo", Toxicol Sci, 112, pp.521~531 (2009)
  23. McGill MR, "Biomarkers of drug-induced liver injury", Adv Pharmacol, 85, pp.221~239 (2019)
  24. Neuman MG, "Biomarkers of drug-induced liver toxicity", Ther Drug Monit, 41, pp.227~234 (2019)
  25. Lammert C, "Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury : search for signals", Hepatology, 47, pp.2003~2009 (2008)
  26. Russmann S, "Current concepts of mechanisms in drug-induced hepatotoxicity", Curr Med Chem, 16, pp.3041~3053 (2009)
  27. Gijbels E, "Mechanisms of drug-induced cholestasis", Methods Mol Biol, 1981, pp.1~14 (2019)
  28. Patel SJ, "Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure", Nat Biotechnol, 30, pp.179~183 (2012)
  29. Chalasani N, "Risk factors for idiosyncratic drug-induced liver injury", Gastroenterology, 138, pp.2246~2259 (2010)
  30. Björnsson ES, "Epidemiology and risk factors for idiosyncratic drug-induced liver injury", Semin Liver Dis, 34, pp.115~122 (2014)
  31. Li H, "The influence of gut microbiota on drug metabolism and toxicity", Expert Opin Drug Metab Toxicol, 12, pp.31~40 (2016)
  32. Teschke R, "Diagnosis and management of drug-induced liver injury(DILI)in patients with pre-existing liver disease", Drug Saf, 39, pp.729~744 (2016)
  33. Chalasani N, "Drug-induced liver injury in patients with preexisting chronic liver disease in drug development : how to identify and manage", Gastroenterology, 151, pp.1046~1051 (2016)
  34. Zimmerman HJ, "Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver" (1999), Lippincott Williams & Wilkins
  35. Reuben A, "Hy’s law", Hepatology, 39, pp.574~578 (2004)
  36. Lo Re V 3rd, "Risk of acute liver failure in patients with drug-induced liver injury : evaluation of Hy’s law and a new prognostic model", Clin Gastroenterol Hepatol, 13, pp.2360~2368 (2015)
  37. Robles-Diaz M, "Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury", Gastroenterology, 147, pp.109~118 (2014)
  38. de Boer YS, "Herbal and dietary supplement-induced liver injury", Clin Liver Dis, 21, pp.135~149 (2017)
  39. García-Cortés M, "Causality assessment methods in drug induced liver injury : strengths and weaknesses", J Hepatol, 55, pp.683~691 (2011)
  40. Teschke R, "Drug and herb induced liver injury : Council for International Organizations of Medical Sciences scale for causality assessment", World J Hepatol, 6, pp.17~32 (2014)
  41. Suh JI, "Anxiety and depression propensities in patients with acute toxic liver injury", World J Gastroenterol, 19, pp.9069~9076 (2013)
  42. Ford R, "Lessons learned from independent central review", Eur J Cancer, 45, pp.268~274 (2009)
  43. Lee WM, "Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure", Gastroenterology, 137, pp.856~864 (2009)
  44. Bateman DN, "Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning : a randomised controlled trial", Lancet, 383, pp.697~704 (2014)
  45. Singh S, "Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure", Dig Dis Sci, 58, pp.1397~1402 (2013)
  46. Hu PF, "Corticosteroid therapy in drug-induced liver injury : pros and cons", J Dig Dis, 20, pp.122~126 (2019)
  47. Hu PF, "Beneficial effect of corticosteroids for patients with severe drug-induced liver injury", J Dig Dis, 17, pp.618~627 (2016)
  48. Reuben A, "Drug-induced acute liver failure: results of a U.S. multicenter, prospective study", Hepatology, 52, pp.2065~2076 (2010)
  49. Mindikoglu AL, "Outcome of liver transplantation for drug-induced acute liver failure in the United States : analysis of the United Network for Organ Sharing database", Liver Transpl, 15, pp.719~729 (2009)
  50. O’Grady JG, "Early indicators of prognosis in fulminant hepatic failure", Gastroenterology, 97, pp.439~445 (1989)
  51. Rudraiah S, "Nuclear receptors as therapeutic targets in liver disease: are we there yet?", Annu Rev Pharmacol Toxicol, 56, pp.605~626 (2016)
  52. Suh JI, "Role of PXR and CAR in cholestasis", Korean J Hepatol, 12, pp.5~15 (2006)
  53. Zhang J, "Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR", Science, 298, pp.422~424 (2002)
  54. Cheng J, "Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity", Drug Metab Dispos, 37, pp.1611~1621 (2009)
  55. Ni HM, "Targeting autophagy for drug-induced hepatotoxicity", Autophagy, 8, pp.709~710 (2012)
  56. Huh D, "Microengineered physiological biomimicry : organs-on-chips", Lab Chip, 12, pp.2156~2164 (2012)
  57. Kimura H, "Organ", body-on-a-chip based on microfluidic technology for drug discovery, 2018, pp.33, 43~48
  58. Beckwitt CH, "Liver ‘organ on a chip’", Exp Cell Res, 363, pp.15~25 (2018)
  59. Xu Y, "Deep learning for drug-induced liver injury", J Chem Inf Model, 55, pp.2085~2093 (2015)
  60. Fraser K, "Advancing predictive hepatotoxicity at the intersection of experimental, in silico, and artificial intelligence technologies", Chem Res Toxicol, 31, pp.412~430 (2018)
  61. Suh JI, "Establishment of tertiary hospital including southeast clinical research center in the era of the 4th industrial revolution", The 58th annual meeting and international symposium of Korean Society of Life Science, pp.71~ (2017), Korean Society of Life Science

관련 논문AI추천

Drug-Induced Liver Injury: Pattern Recognition and Future DirectionsEizaburo Sasatomi, Paul H. Hayashi, Tanvir Haque거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제1호약인성간손상의 미해결 논점김동준대한내과학회 · 대한내과학회지2011 · 제81권 제1호The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis김상균, 김영석, 김홍수, 이세환, 장재영, 정승원, 조영덕, 진소영, 차상우, Boo Sung Kim, Hee Yoon Jang, Hye Young Ju, Min Gyu Kong, Sung Ae Woo대한간학회 · Clinical and Molecular Hepatology2012 · 제18권 제2호A Drug-Induced Liver Injury by Western Medication손창규대한한방내과학회 · 대한한방내과학회지2015 · 제36권 제1호Awareness of the Causes of Drug-Induced Liver Injury: A Case of Hepatotoxicity Resulting from Antipsychotics손창규대한한방내과학회 · 대한한방내과학회지2023 · 제44권 제4호Drug induced liver injury: East versus West – a systematic review and meta-analysisEdwin Chan, En Xian Sarah Low, Qishi Zheng, Seng Gee Lim대한간학회 · Clinical and Molecular Hepatology2020 · 제26권 제2호

이 간행물의 다른 논문 (10건)

First step to international journal by indexing PMC and DOAJ최준혁pp. 1-1Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment장경미pp. 13-21Reproductive toxic agents in work environments and related cases in KoreaChulyong Parkpp. 22-31Nasal tip plasty using three-dimensional printed polycaprolactone (Smart Ball®)Geon Woo Kim, Won Kyung Kang, 김주형pp. 32-39Correlation between anterior thigh pain and morphometric mismatch of femoral stemHaksun Chung, So Hak Chungpp. 40-46
원문 보기